Pancreatoblastoma
Prepared with OnCo (onco.cc/prep/pancreatoblastoma/). Orientation, not medical advice; your team knows your case.
My details
What I know, what is unclear, changes to discuss
Saved in this browserMy questions
15 on the sheet- 1.What is my exact diagnosis, stage, and grade, and which tests established them?
- 2.Which biomarkers have been tested on my tumour (for example Serum alpha-fetoprotein, Squamoid nests and acinar differentiation on histology; trypsin and BCL10 immunohistochemistry, CTNNB1 mutation or APC loss; nuclear beta-catenin staining, 11p loss of heterozygosity, Germline APC testing where familial adenomatous polyposis is suspected), and what were the results?
- 3.Which subtype is my cancer, and does that change the recommended treatment?
- 4.Is germline (inherited) genetic testing recommended for me or my family?
- 5.For my situation (diagnosis and staging), which of the standard options do you recommend and why?
- 6.For my situation (resectable at diagnosis), which of the standard options do you recommend and why?
- 7.For my situation (unresectable at diagnosis), which of the standard options do you recommend and why?
- 8.Am I a candidate for Cisplatin, Doxorubicin, and what side effects should I expect?
- 9.For my situation (metastatic or relapsed), which of the standard options do you recommend and why?
- 10.Am I a candidate for Cisplatin, Doxorubicin, and what side effects should I expect?
- 11.For my situation (survivorship), which of the standard options do you recommend and why?
- 12.Would a second opinion at a high-volume centre change anything, and can you help arrange it?
- 13.What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?
- 14.I read that “No prospective trial exists or is likely; treatment is extrapolated from hepatoblastoma and pooled registries”. How does that affect my plan?
- 15.I read that “Relapsed and metastatic disease has no established second-line therapy”. How does that affect my plan?
The words I may hear
- Metastasis: Cancer that has spread from where it started to distant parts of the body, travelling through the blood or lymph.
- Resection margins (R0 / R1 / R2): Whether the edge of the removed tissue is free of cancer.
- Cancer cachexia: Severe loss of weight and muscle in advanced cancer that eating more cannot reverse on its own.
- Grade: How abnormal the cancer cells look under the microscope, from grade 1 (close to normal, slow) to grade 3 or 4 (wildly abnormal, fast).
- Whipple procedure (pancreaticoduodenectomy): The big operation for cancers of the head of the pancreas: the surgeon removes the pancreatic head, the duodenum, the gallbladder and part of the bile duct, then reconnects everything.
- Neoadjuvant / adjuvant / perioperative: Neoadjuvant therapy is treatment given before surgery, adjuvant therapy is treatment given after it, and perioperative therapy is both.
Tests and results to bring
Diagnosis and staging: Imaging of abdomen and chest, serum alpha-fetoprotein and biopsy; genetic review for Beckwith-Wiedemann syndrome and familial adenomatous polyposis.
Resectable at diagnosis: Complete resection (pancreatoduodenectomy or distal pancreatectomy); adjuvant chemotherapy after incomplete resection.
Unresectable at diagnosis: Neoadjuvant cisplatin and doxorubicin (PLADO, as in hepatoblastoma) followed by delayed resection when the tumour shrinks.
Biomarker results to ask for: Serum alpha-fetoprotein (raised in most; response and relapse marker), Squamoid nests and acinar differentiation on histology; trypsin and BCL10 immunohistochemistry, CTNNB1 mutation or APC loss (Wnt pathway); nuclear beta-catenin staining, 11p loss of heterozygosity (Beckwith-Wiedemann locus), Germline APC testing where familial adenomatous polyposis is suspected, CT or MRI of abdomen and chest for staging.
Scans and tests linked to this cancer: CT (computed tomography), Germline (hereditary) testing, MRI.
Bring copies of scan reports, pathology and blood results, and a list of every medicine and supplement.
The treatments I may be offered
- Metastatic or relapsed: Cisplatin and doxorubicin-based chemotherapy with resection of residual disease where possible; radiotherapy for unresectable residual tumour; international registry enrolment. (Cisplatin, Doxorubicin, Metastasis)
- Survivorship: Lifelong follow-up for pancreatic insufficiency, diabetes and the late effects of platinum and anthracycline chemotherapy. (Oncofertility and fertility preservation, Cancer cachexia)
From the standard of care recorded for this cancer; which apply depends on your stage and biomarkers. Ask which the team recommends and why.